Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2026 07:00 ET | Source: Arvinas Inc.

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

– Arvinas and Pfizer to receive $85 million in upfront and transition payments with potential for additional $320 million in development, regulatory, and commercial milestones and tiered royalites on...
May 04, 2026 17:00 ET | Source: DENTSPLY SIRONA Inc.

Dentsply Sirona Expands U.S. Distribution Footprint Through Enhanced Agreement with Atlanta Dental Supply

CHARLOTTE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, today announced an...
May 04, 2026 08:05 ET | Source: Adeia Inc.

L’Oréal and Adeia Enter Multi-Year License Agreement

L’Oréal and Adeia Enter Multi-Year License Agreement
May 04, 2026 07:00 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema

— BioCryst grants Irish affiliate of Neopharmed Gentili exclusive license to commercialize navenibart for hereditary angioedema in Europe — — BioCryst to receive $70M upfront, up to $275M in future...
May 01, 2026 08:00 ET | Source: The Metals Company

NOAA Determines TMC USA’s Consolidated Deep-Seabed Mining Application is in Full Compliance

Full compliance represents a key milestone in the regulatory approval process for TMC USA’s consolidated exploration and commercial recovery applicationTMC USA’s consolidated application submitted...
April 30, 2026 09:00 ET | Source: Gemini Space Station, Inc.

Gemini Receives DCO License Approval From CFTC

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Today, Gemini Space Station, Inc. (Gemini) (NASDAQ:GEMI) announced that Gemini Olympus, LLC (Olympus), an affiliate, received a Derivatives Clearing...
April 30, 2026 07:00 ET | Source: AC Immune SA

AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease

AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease Treatment of first patient in Cohort AD4 in ABATE trial triggers $12...
April 28, 2026 14:24 ET | Source: Mann Mechanics

UK Inventor Publishes Mathematical Framework for Disciplined Supply Creation Across Money, Credits, and Critical Resources. Introducing PDM and Mann Mechanics

London, LONDON, April 28, 2026 (GLOBE NEWSWIRE) -- Valraj Singh Mann, a UK-based inventor and founder of Mann Mechanics Ltd, has today published the v1.0 specification stack for Progressive...
April 28, 2026 08:00 ET | Source: Juniper Biosciences

Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment

BRIDGEWATER, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences today announced a strategic licensing agreement with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the...
April 27, 2026 09:38 ET | Source: VERSES AI Inc.

Prodigii Licenses VERSES® Technology

VANCOUVER, British Columbia, April 27, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB: VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation...